Choisissez votre pays / Select your country

Ninalia NIPT The prenatal trisomy screening test based on maternal blood sample

Recommendations

Eurofins Biomnis follows the International recommendations of the American Congress of Obstetricians and Gynecologists (ACOG) and the Society for Maternal–Fetal Medicine (SMFM) in relation to the indications for non-invasive prenatal screening for patients at risk.

Main recommendations

  • Risk greater than 1/1000 according to maternal serum markers
  • Mothers aged > 38 years for patients that did not benefit of the maternal serum markers assay
  • History of pregnancy with foetal aneuploidies
  • Relative is carrier of a Robertsonian translocation involving chromosome 13 or 21
  • Pregnancy with twins
  • 1st line screening

An invasive diagnostic procedure should be considered for ultrasound abnormalities.

Other indications

We therefore encourage you to directly contact Eurofins Biomnis at international@biomnis.com with any questions going beyond the above main recommendations.

Find your nearest testing centre As Ninalia NIPT requires a specific sample tube, don’t forget to make an appointment in advance with your local laboratory for specimen collection.

Vous avez refusé de partager votre position.
Désolé. Nous n'arrivons pas à savoir où vous êtes...
Il faut nous autoriser à voir votre position...
Votre navigateur ne possède pas cette fonctionnalité.

Partner laboratories

out of laboratories in total out of laboratories in total